Published in J Exp Med on January 01, 1990
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun (1993) 1.62
Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med (2000) 1.55
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun (1990) 1.44
Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun (1996) 1.33
Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19
Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect Immun (1992) 1.19
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun (1997) 1.12
Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun (1994) 1.12
Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. Emerg Infect Dis (2001) 1.09
Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08
Adhesion of Bordetella pertussis to eukaryotic cells requires a time-dependent export and maturation of filamentous hemagglutinin. Proc Natl Acad Sci U S A (1993) 1.07
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun (2006) 0.98
Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier. Infect Immun (1996) 0.97
Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun (2012) 0.96
Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun (2000) 0.95
Purification and immunological characterization of a GroEL-like protein from Bordetella pertussis. Infect Immun (1991) 0.95
Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95
Pertussis vaccine: a critique. Pediatr Infect Dis J (2009) 0.91
Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection. Infect Immun (1993) 0.90
Biochemical and immunological properties of two forms of pertactin, the 69,000-molecular-weight outer membrane protein of Bordetella pertussis. Infect Immun (1993) 0.89
Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model. Infect Immun (2002) 0.84
Toward a new vaccine for pertussis. Proc Natl Acad Sci U S A (2014) 0.83
Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum. J Clin Microbiol (1992) 0.79
Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiol (2009) 0.78
Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid. Infect Immun (1993) 0.78
Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets. Infect Immun (2017) 0.77
c-di-GMP enhances protective innate immunity in a murine model of pertussis. PLoS One (2014) 0.76
CD71(+) erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. Sci Rep (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A (1989) 3.13
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect Immun (1985) 1.66
Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun (1985) 1.64
Pertussis: The histological Lesion in the Respiratory Tract. J Med Res (1912) 1.45
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Monoclonal antibodies as probes of tetanus toxin structure and function. Infect Immun (1983) 1.34
Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J Infect Dis (1989) 1.18
Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b. Infect Immun (1985) 1.16
Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA (1987) 1.06
Transfer of humoral secretory and cellular immunity from mother to offspring. Curr Top Pathol (1979) 1.06
Type-specific efficacy of acellular pertussis vaccine. Am J Dis Child (1988) 0.96
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Rapid assay for screening and characterizing microorganisms for the ability to degrade polychlorinated biphenyls. Appl Environ Microbiol (1986) 5.69
Extensive degradation of Aroclors and environmentally transformed polychlorinated biphenyls by Alcaligenes eutrophus H850. Appl Environ Microbiol (1987) 3.82
Evidence for novel mechanisms of polychlorinated biphenyl metabolism in Alcaligenes eutrophus H850. Appl Environ Microbiol (1987) 3.68
Polychlorinated biphenyl dechlorination in aquatic sediments. Science (1987) 3.64
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med (1990) 3.46
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Coordinated force production in multi-finger tasks: finger interaction and neural network modeling. Biol Cybern (1998) 3.17
Enslaving effects in multi-finger force production. Exp Brain Res (2000) 2.92
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature (2001) 2.65
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest (1976) 2.32
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun (2001) 2.26
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics (1995) 2.20
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med (1996) 2.18
Search for a human breast cancer virus. Nature (1971) 2.14
Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun (1994) 2.06
American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer (1998) 2.06
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin Diagn Lab Immunol (1996) 1.94
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Evaluation of pertussis in U.S. Marine Corps trainees. Clin Infect Dis (1997) 1.79
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc Natl Acad Sci U S A (1998) 1.76
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Epidemiological considerations of cancer of the gallbladder, bile ducts and salivary glands in the rubber industry. J Occup Med (1970) 1.68
Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur J Immunol (1991) 1.67
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells. Infect Immun (1984) 1.56
Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect Immun (1994) 1.54
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics (1995) 1.46
The rating form of IBD patient concerns: a new measure of health status. Psychosom Med (1992) 1.46
Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ (2009) 1.44
Fulminating encephalopathy associated with Shigella flexneri infection. Arch Dis Child (1983) 1.43
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes. Infect Immun (1986) 1.40
Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns. J Mol Biol (1994) 1.38
Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts. J Biol Chem (1984) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Functional domains present in the mycobacterial hemagglutinin, HBHA. J Bacteriol (1999) 1.32
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
The variability of estrogen receptors in metastatic breast cancer. Am J Surg (1979) 1.32
A principle of error compensation studied within a task of force production by a redundant set of fingers. Exp Brain Res (1998) 1.30
Biological approaches for polychlorinated biphenyl degradation. Basic Life Sci (1988) 1.29
Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature (1979) 1.28
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Changes in the force-sharing pattern induced by modifications of visual feedback during force production by a set of fingers. Exp Brain Res (1998) 1.23
The second Geneva Consensus: Recommendations for novel live TB vaccines. Vaccine (2010) 1.18
Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer (1983) 1.17
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
The effect of fatigue on multifinger co-ordination in force production tasks in humans. J Physiol (2000) 1.15
Binding of Actinomyces naeslundii to glycosphingolipids. Infect Immun (1987) 1.15
Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, binds to novel alpha-galactosyl derivatives of ganglioside GD1b. J Biol Chem (1989) 1.15
Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage (1992) 1.14
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
Racial differences in breast cancer patients. J Natl Cancer Inst (1985) 1.12
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
A 160-kilodalton epithelial cell surface glycoprotein recognized by plant lectins that inhibit the adherence of Actinomyces naeslundii. Infect Immun (1986) 1.09
Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08
Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Ann Oncol (2010) 1.07
Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07